Key Clinical Message
Recently, hypoxia-inducible factor prolyl hydroxylase (HIF-PH)
inhibitors have been used for renal anemia, but side effects have also
been reported. We report on the association of central hypothyroidism
and cholesterol with ï½’oxadustat.